Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)

By Cooper C.   Reginster J.-Y.   Cortet B.   Diaz-Curiel M.   Lorenc R.S.   Kanis J.A.   Rizzoli R.  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 475-491

Informa Healthcare

Access to resources Recommend Favorite

Long-term use of bisphosphonates in osteoporosis

By Rizzoli René  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 309-315

Future Medicine

Access to resources Recommend Favorite

Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women

By Ringe J. D.   Christodoulakos G. E.   Mellström D.   Petto H.   Nickelsen T.   Marín F.   Pavo I.  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2677-2687

Informa Healthcare

Access to resources Recommend Favorite

Long dosing intervals in the treatment of postmenopausal osteoporosis

By Lewiecki E. Michael  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2617-2625

Informa Healthcare

Access to resources Recommend Favorite

Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis

By Marini Francesca   Falchetti Alberto   Silvestri Sandra   Bagger Yu   Luzi Ettore   Tanini Annalisa   Christiansen Claus   Brandi Maria Luisa  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2609-2615

Informa Healthcare

Access to resources Recommend Favorite